Suscribirse para recibir un correo electrónico cada vez que se introduzca un ítem en esta colección.

Fecha publicación	Título	Tipo	Autor(es)
2015	Molecular and cellular basis for immunomodulation with monoclonal antibodies	Articulo	Melero, I. (Ignacio)
2008	TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients	Articulo	Honorato, B. (Beatriz); Alcalde, J. (Juan); Martinez-Monge, R. (Rafael), et al
2006	Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy	Articulo	Zarate, R. (Ruth); Arias, F. (F.); Bandres, E. (Eva), et al
2001	Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes	Articulo	Sarobe, P. (Pablo); Huarte, E. (Eduardo); Lasarte, J.J. (Juan José), et al
1999	T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides	Articulo	Lopez-Diaz-de-Cerio, A. (Ascensión); Casares, N. (Noelia); Lasarte, J.J. (Juan José), et al
1999	Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide	Articulo	Lasarte, J.J. (Juan José); Corrales, F.J. (Fernando José); Casares, N. (Noelia), et al
2002	Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins	Articulo	Sarobe, P. (Pablo); Lasarte, J.J. (Juan José); Casares, N. (Noelia), et al
2002	Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus	Articulo	Arribillaga, L. (Laura); Lopez-Diaz-de-Cerio, A. (Ascensión); Sarobe, P. (Pablo), et al
2003	A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage	Articulo	Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Boya, P. (Patricia), et al
2003	Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses	Articulo	Lopez-Diaz-de-Cerio, A. (Ascensión); Lasarte, J.J. (Juan José); Casares, N. (Noelia), et al
2001	Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity	Articulo	Casares, N. (Noelia); Lasarte, J.J. (Juan José); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2003	CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination	Articulo	Casares, N. (Noelia); Arribillaga, L. (Laura); Sarobe, P. (Pablo), et al
2000	In situ localization of anion exchanger-2 in the human kidney	Articulo	Castillo, J. (José E.); Martinez-Anso, E. (Eduardo); Malumbres, R. (Raquel), et al
2007	The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience	Articulo	Rodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007	Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group	Articulo	Rodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007	The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma	Articulo	Rodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007	Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience	Articulo	Rodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2004	Indolent lymphoma: the pathologist's viewpoint	Articulo	Pileri, S.A. (S.A.); Zinzani, P.L. (P.L.); Went, P. (P.), et al
2003	Feasibility of idiotype vaccination in relapsed B-cell malignancies	Articulo	Inoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2004	Active immunotherapy in the treatment of haematological neoplasias	Articulo	Inoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Lopez-Diaz-de-Cerio, A. (Ascensión), et al

Envíos recientes

Molecular and cellular basis for immunomodulation with monoclonal antibodies

TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses